300705 九典製藥
按盤價 
15.730 -1.720 (-9.857%)
15.730 -1.720 (-9.857%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 20.648 | 20.889 | 20.340 | 21.110 | 10.300 |
| 總資產報酬率 ROA (%) | 14.717 | 14.244 | 13.335 | 14.204 | 7.469 |
| 投入資產回報率 ROIC (%) | 17.150 | 16.689 | 15.446 | 16.449 | 8.478 | 邊際利潤分析 |
| 銷售毛利率 (%) | 73.760 | 77.151 | 77.776 | 78.503 | 74.848 |
| 營業利潤率 (%) | 23.669 | 14.647 | 12.523 | 13.875 | 9.377 |
| 息稅前利潤/營業總收入 (%) | 24.108 | 15.160 | 13.071 | 14.713 | 9.786 |
| 淨利潤/營業總收入 (%) | 20.958 | 13.677 | 11.594 | 12.548 | 8.410 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 91.402 | 93.873 | 97.379 | 96.756 | 92.283 |
| 價值變動淨收益/利潤總額(%) | 0.502 | 0.530 | 0.635 | 1.260 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -0.425 | 1.937 | -0.375 | 0.159 | -0.967 | 償債能力分析 |
| 流動比率 (X) | 4.229 | 3.441 | 2.715 | 2.755 | 2.783 |
| 速動比率 (X) | 3.347 | 2.802 | 2.173 | 2.176 | 1.937 |
| 資產負債率 (%) | 26.466 | 31.274 | 32.486 | 37.009 | 26.093 |
| 帶息債務/全部投入資本 (%) | 10.121 | 12.594 | 18.160 | 23.693 | -- |
| 股東權益/帶息債務 (%) | 836.210 | 645.054 | 430.872 | 307.714 | 867.393 |
| 股東權益/負債合計 (%) | 277.845 | 219.758 | 207.823 | 170.203 | 283.246 |
| 利息保障倍數 (X) | 44.721 | 67.804 | 21.978 | 18.015 | 19.621 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 60.988 | 67.104 | 54.711 | 45.688 | 0.000 |
| 存貨周轉天數 (天) | 143.552 | 148.212 | 158.600 | 189.103 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/01/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
